Henry Wheeler Center for Emerging & Neglected Diseases

Director
Jeff Cox
Email
jeff.cox@berkeley.edu
Telephone
(510) 664-7206
Staff contact
Michael Eichberg
Email
meichberg@berkeley.edu
Mailing address

444A Li Ka Shing Center, Berkeley, CA 94720-3370



In News

February 5, 2021

Can hepatitis C drugs help remdesivir fight COVID-19?

Since the coronavirus pandemic began, only one antiviral drug, remdesivir, has been approved in the United States for treatment of COVID-19, but it barely works and is toxic to the liver. Researchers at UC Berkeley have found 20 compounds that, in combination with remdesivir, are much better than remdesivir alone in protecting human lung cells from SARS-CoV-2, the virus that causes COVID-19.